Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Gαs in the development of human obesity

Dominique N Long, Sarah McGuire, Michael A. Levine, Lee S. Weinstein, Emily L. Germain-Lee

Research output: Contribution to journalArticle

Abstract

Context: Obesity is a prominent feature of Albright hereditary osteodystrophy (AHO), a disorder caused by heterozygous GNAS mutations that disrupt the stimulatory G protein α-subunit Gαs. Because Gαs is paternally imprinted in certain hormone target tissues, maternal inheritance of AHO leads to multihormone resistance [pseudohypoparathyroidism type 1a (PHP1a)], whereas paternal inheritance leads to AHO alone [pseudopseudohypoparathyroidism (pseudoPHP)]. Classically, the obesity in AHO is described as occurring similarly in both conditions. Setting: This observational study was conducted at the General Clinical Research Center, Johns Hopkins University School of Medicine; National Institutes of Health. Patients: Fifty-three patients with AHO (40 with PHP1a and 13 with pseudoPHP) and two with progressive osseous heteroplasia were studied. Main Outcome Measures: Main outcome measures were weight and height SD score (SDS), body mass index (BMI) percentiles, and BMI z-scores. Results: Patients with PHP1a had significantly greater mean weight SDS, BMI percentages, and BMI z-scores compared with patients with pseudoPHP. These differences in BMI were secondary to adipose content based on dual energy x-ray absorptiometry analysis. The mean BMI z-score ± SEM for PHP1a was 2.31 ± 0.18 compared with 0.65 ± 0.31 in pseudoPHP (P = 0.000032). Twenty-five of 40 (62.5%) patients with PHP1a had mean BMI z-scores greater than two SDS above the mean, whereas no patients with pseudoPHP had BMI z-scores in this range. Conclusions: Although the AHO phenotype for PHP1a and pseudoPHP has been thought to be similar, we have found that obesity is a more prominent feature in PHP1a than in pseudoPHP and that severe obesity is characteristic of PHP1a specifically. These findings may implicate paternal imprinting of Gαs in the development of human obesity.

Original languageEnglish (US)
Pages (from-to)1073-1079
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume92
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Pseudopseudohypoparathyroidism
Pseudohypoparathyroidism
Units of measurement
Protein Subunits
Human Development
GTP-Binding Proteins
Medicine
Body Mass Index
Obesity
Health
Hormones
Tissue
X rays
Scanning electron microscopy
Outcome Assessment (Health Care)
Weights and Measures
Morbid Obesity
Imprinting (Psychology)
National Institutes of Health (U.S.)
Observational Studies

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Gαs in the development of human obesity. / Long, Dominique N; McGuire, Sarah; Levine, Michael A.; Weinstein, Lee S.; Germain-Lee, Emily L.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 92, No. 3, 03.2007, p. 1073-1079.

Research output: Contribution to journalArticle

@article{bc1642ba378e4e7f9c6b1b0f2dbd3998,
title = "Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Gαs in the development of human obesity",
abstract = "Context: Obesity is a prominent feature of Albright hereditary osteodystrophy (AHO), a disorder caused by heterozygous GNAS mutations that disrupt the stimulatory G protein α-subunit Gαs. Because Gαs is paternally imprinted in certain hormone target tissues, maternal inheritance of AHO leads to multihormone resistance [pseudohypoparathyroidism type 1a (PHP1a)], whereas paternal inheritance leads to AHO alone [pseudopseudohypoparathyroidism (pseudoPHP)]. Classically, the obesity in AHO is described as occurring similarly in both conditions. Setting: This observational study was conducted at the General Clinical Research Center, Johns Hopkins University School of Medicine; National Institutes of Health. Patients: Fifty-three patients with AHO (40 with PHP1a and 13 with pseudoPHP) and two with progressive osseous heteroplasia were studied. Main Outcome Measures: Main outcome measures were weight and height SD score (SDS), body mass index (BMI) percentiles, and BMI z-scores. Results: Patients with PHP1a had significantly greater mean weight SDS, BMI percentages, and BMI z-scores compared with patients with pseudoPHP. These differences in BMI were secondary to adipose content based on dual energy x-ray absorptiometry analysis. The mean BMI z-score ± SEM for PHP1a was 2.31 ± 0.18 compared with 0.65 ± 0.31 in pseudoPHP (P = 0.000032). Twenty-five of 40 (62.5{\%}) patients with PHP1a had mean BMI z-scores greater than two SDS above the mean, whereas no patients with pseudoPHP had BMI z-scores in this range. Conclusions: Although the AHO phenotype for PHP1a and pseudoPHP has been thought to be similar, we have found that obesity is a more prominent feature in PHP1a than in pseudoPHP and that severe obesity is characteristic of PHP1a specifically. These findings may implicate paternal imprinting of Gαs in the development of human obesity.",
author = "Long, {Dominique N} and Sarah McGuire and Levine, {Michael A.} and Weinstein, {Lee S.} and Germain-Lee, {Emily L.}",
year = "2007",
month = "3",
doi = "10.1210/jc.2006-1497",
language = "English (US)",
volume = "92",
pages = "1073--1079",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Gαs in the development of human obesity

AU - Long, Dominique N

AU - McGuire, Sarah

AU - Levine, Michael A.

AU - Weinstein, Lee S.

AU - Germain-Lee, Emily L.

PY - 2007/3

Y1 - 2007/3

N2 - Context: Obesity is a prominent feature of Albright hereditary osteodystrophy (AHO), a disorder caused by heterozygous GNAS mutations that disrupt the stimulatory G protein α-subunit Gαs. Because Gαs is paternally imprinted in certain hormone target tissues, maternal inheritance of AHO leads to multihormone resistance [pseudohypoparathyroidism type 1a (PHP1a)], whereas paternal inheritance leads to AHO alone [pseudopseudohypoparathyroidism (pseudoPHP)]. Classically, the obesity in AHO is described as occurring similarly in both conditions. Setting: This observational study was conducted at the General Clinical Research Center, Johns Hopkins University School of Medicine; National Institutes of Health. Patients: Fifty-three patients with AHO (40 with PHP1a and 13 with pseudoPHP) and two with progressive osseous heteroplasia were studied. Main Outcome Measures: Main outcome measures were weight and height SD score (SDS), body mass index (BMI) percentiles, and BMI z-scores. Results: Patients with PHP1a had significantly greater mean weight SDS, BMI percentages, and BMI z-scores compared with patients with pseudoPHP. These differences in BMI were secondary to adipose content based on dual energy x-ray absorptiometry analysis. The mean BMI z-score ± SEM for PHP1a was 2.31 ± 0.18 compared with 0.65 ± 0.31 in pseudoPHP (P = 0.000032). Twenty-five of 40 (62.5%) patients with PHP1a had mean BMI z-scores greater than two SDS above the mean, whereas no patients with pseudoPHP had BMI z-scores in this range. Conclusions: Although the AHO phenotype for PHP1a and pseudoPHP has been thought to be similar, we have found that obesity is a more prominent feature in PHP1a than in pseudoPHP and that severe obesity is characteristic of PHP1a specifically. These findings may implicate paternal imprinting of Gαs in the development of human obesity.

AB - Context: Obesity is a prominent feature of Albright hereditary osteodystrophy (AHO), a disorder caused by heterozygous GNAS mutations that disrupt the stimulatory G protein α-subunit Gαs. Because Gαs is paternally imprinted in certain hormone target tissues, maternal inheritance of AHO leads to multihormone resistance [pseudohypoparathyroidism type 1a (PHP1a)], whereas paternal inheritance leads to AHO alone [pseudopseudohypoparathyroidism (pseudoPHP)]. Classically, the obesity in AHO is described as occurring similarly in both conditions. Setting: This observational study was conducted at the General Clinical Research Center, Johns Hopkins University School of Medicine; National Institutes of Health. Patients: Fifty-three patients with AHO (40 with PHP1a and 13 with pseudoPHP) and two with progressive osseous heteroplasia were studied. Main Outcome Measures: Main outcome measures were weight and height SD score (SDS), body mass index (BMI) percentiles, and BMI z-scores. Results: Patients with PHP1a had significantly greater mean weight SDS, BMI percentages, and BMI z-scores compared with patients with pseudoPHP. These differences in BMI were secondary to adipose content based on dual energy x-ray absorptiometry analysis. The mean BMI z-score ± SEM for PHP1a was 2.31 ± 0.18 compared with 0.65 ± 0.31 in pseudoPHP (P = 0.000032). Twenty-five of 40 (62.5%) patients with PHP1a had mean BMI z-scores greater than two SDS above the mean, whereas no patients with pseudoPHP had BMI z-scores in this range. Conclusions: Although the AHO phenotype for PHP1a and pseudoPHP has been thought to be similar, we have found that obesity is a more prominent feature in PHP1a than in pseudoPHP and that severe obesity is characteristic of PHP1a specifically. These findings may implicate paternal imprinting of Gαs in the development of human obesity.

UR - http://www.scopus.com/inward/record.url?scp=33947520961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947520961&partnerID=8YFLogxK

U2 - 10.1210/jc.2006-1497

DO - 10.1210/jc.2006-1497

M3 - Article

C2 - 17164301

AN - SCOPUS:33947520961

VL - 92

SP - 1073

EP - 1079

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -